XOMA Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health...

Stats
Dagens volum	7 935.00
Gjennomsnittsvolum	18 096.00
Markedsverdi	288.09M
EPS	$0 ( 2024-03-14 )
Neste inntjeningsdato	( $-0.710 ) 2024-05-14
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-6.13
ATR14	$0.240 (0.98%)

Insider Trading

Date	Person	Action	Amount	type
2024-01-08	Hughes Owen	Buy	275 000	Performance Stock Units
2023-10-03	Sitko Bradley	Buy	250	Common Stock
2023-10-02	Sitko Bradley	Buy	1 500	Common Stock
2023-10-02	Hughes Owen	Buy	1 000	Common Stock
2023-09-26	Hughes Owen	Buy	2 499	Common Stock

INSIDER POWER
97.03
Last 95 transactions
Buy: 1 668 857 \| Sell: 210 377

XOMA Corp Korrelasjon

10 Mest positive korrelasjoner
OWL	0.94
MACK	0.937
BRIVU	0.932
IBKR	0.932
CSWI	0.931
MSDA	0.93
FLEX	0.93
TRIP	0.93
SKYA	0.929
CRZN	0.928

10 Mest negative korrelasjoner
KRKR	-0.94
BHTG	-0.937
WISA	-0.932
AGRX	-0.928
CAR	-0.925
TBLT	-0.923
NYMT	-0.921
VRSN	-0.918
CFRX	-0.917
GPRO	-0.917

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

XOMA Corp Økonomi

Annual	2023
Omsetning:	$4.76M
Bruttogevinst:	$3.86M (81.08 %)
EPS:	$-3.56

FY	2023
Omsetning:	$4.76M
Bruttogevinst:	$3.86M (81.08 %)
EPS:	$-3.56

FY	2022
Omsetning:	$6.03M
Bruttogevinst:	$5.93M (98.39 %)
EPS:	$-1.500

FY	2021
Omsetning:	$38.16M
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$0.690

Financial Reports:

No articles found.

XOMA Corp

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.